Furthermore, CDAI has been reported to be associated with lower all-cause and/or factor-specific mortality in stroke [33], diabetes [31], and chronic kidney disease patients [34], suggesting a broad protective role for CDAI in diverse populations. Here, CDAN1 is linked to diabetes mellitus.